A double-blind, placebo-controlled trial to assess safety and tolerability of (thetanix) bacteroides thetaiotaomicron in adolescent crohn's disease
- Richard Hansen
- , Ian R. Sanderson
- , Rafeeq Muhammed
- , Stephen Allen
- , Christos Tzivinikos
- , Paul Henderson
- , Lisa Gervais
- , Ian B. Jeffery
- , David P. Mullins
- , Eileen A. O'Herlihy
- , John D. Weinberg
- , Geoff Kitson
- , Richard K. Russell
- , David C. Wilson
- NHS Greater Glasgow and Clyde
- Queen Mary University of London
- Birmingham Women's and Children's NHS Foundation Trust
- Liverpool School of Tropical Medicine
- Alder Hey Children's NHS Foundation Trust
- NHS Lothian
- University of Edinburgh
- 4D pharma plc
- ProPharma Partners Limited
Research output: Contribution to journal › Article › peer-review